Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 66 for “"Drug Repositioning"”.
-
Bioinformatic approaches to drug repositioning
Repositioning existing drugs for new therapeutic uses is an efficient approach to drug discovery. However, most successful repositioning cases to date have been serendipitous; the goal of my thesis was to use computational methods to rationally discover drug repositioning candidates. I first …
-
Drug repositioning in chemoprevention of colorectal cancer
… potential beneficial effects of already-approved drugs on the chemoprevention of CRC, especially in high-risk groups. MethodsPapers I, II, and III were population-based cohort studies. By accessing several nationwide Swedish registers, we identified individuals who had ever been previously …
-
Drug discovery against malaria parasite: drug repositioning strategy
… year and there are ever present problems due to drug resistance. In this work, I used drug-repositioning strategy with bisphosphonates to discover a lead that is active against malaria in vivo. The developmental procedures include, in vitro high throughput screening, x-ray crystallography and …
-
Relation Prediction over Biomedical Knowledge Bases for Drug Repositioning
… task of biomedical research. Since all candidate drugs cannot be tested with animal and clinical trials, in vitro approaches are first attempted to identify promising candidates. Likewise, identifying other essential relations (e.g., causation, prevention) between biomedical entities is also …
-
Explainable artificial intelligence for patient stratification and drug repositioning
… robust patient stratification methods as well as drugs tailored to homogeneous subgroups of patients from a heterogeneous population. Developing de novo drugs is expensive and time consuming with an ultimately low FDA approval rate. These limitations make developing new drugs for a small portion …
-
Protein Binding Site Similarities as Driver for Drug Repositioning
Drug repositioning applies existing drugs to new disease indications. A prerequisite for drug repurposing is drug promiscuity - a drug's ability to bind to several targets, possibly leading to side effects on the other hand. One reason for drug promiscuity is binding site similarity between …
-
Predicting potential drugs and drug-drug interactions for drug repositioning
The purpose of drug repositioning is to predict novel treatments for existing drugs. It saves time and reduces cost in drug discovery, especially in preclinical procedures. In drug repositioning, the challenging objective is to identify reasonable drugs with strong evidence. Recently, benefiting …
-
Ontology-based methods for disease similarity estimation and drug repositioning
… early disease diagnosis and development of new drugs. The growing collection of gene-function and gene-disease data has instituted a need for formal knowledge representation in order to extract information. Ontologies have been successfully applied to represent such knowledge, and data mining …
-
Computational Drug Repositioning Based on Integrated Similarity Measures and Deep Learning
Drug repositioning is an emerging approach in pharmaceutical research for identifying novel therapeutic potentials for approved drugs and discover therapies for untreated diseases. Due to its time and cost efficiency, drug repositioning plays an instrumental role in optimizing the drug development …
-
A systematic pathway-based network approach for in silico drug repositioning
Drug repositioning, the method of finding new uses for existing drugs, holds the potential to reduce the cost and time of drug development. Successful drug repositioning strategies depend heavily on the availability and aggregation of different drug and disease databases. Moreover, to yield greater …
-
Toward building recommendation systems for cancer drug repositioning trials in precision medicine
… mechanistic evidence for potential cancer drug repositioning. These gaps highlight the need for informatics-driven approaches that can extract, integrate, and explain complex patterns across heterogeneous biomedical data sources to support decision-making in precision oncology. This …
-
Structure based drug repositioning by exploiting structural properties of drug's binding mode
… process. In light of these challenges, drug repositioning, the utilization of known drugs for a new medical indication, has emerged as an increasingly important strategy for the new drug discovery. Availability of prior knowledge regarding safety, efficacy and the appropriate …
-
Investigating drug repositioning as a route to combat drug resistance in Plasmodium falciparum Malaria
… over time there has been an emergence of drug resistance to most of the antimalarial therapies available. There is an urgent need for novel therapeutic drugs to become available. Traditional drug development pipelines and research would have significant time and cost implications, whereas …
-
Lead optimisation of dehydroemetine as an antimalarial option through drug repositioning and molecular modelling
… There is a great need for new anti-malarial drugs, but traditional drug discovery timelines take approximately 10-17 years. Drug repositioning offers a very effective alternative to de novo drug design and could minimise the long timescales involved in the process of bringing a drug to the …
-
Exploring Predictive Approaches in Computational Drug Repositioning: A Pathway to Safer and Faster Drug Development
The development and approval process for new drugs is time-intensive, costly and carries only a 10% chance of success. Drug repositioning - the strategy of repurposing drugs that have previously completed some or all clinical trial stages for new indications – can save substantial time and …
-
A network based approach to drug repositioning identifies candidates for breast cancer and prostate cancer
The high cost and the long time required to bring drugs into commerce is driving efforts to repurpose FDA approved drugs—to find new uses for which they weren’t intended, and to thereby reduce the overall cost of commercialization, and shorten the lag between drug discovery and availability. In …
-
Stromal Gene Signatures as Source of Targets for Drug-Repositioning and Prognostic Biomarkers in Prostate Cancer
… open new opportunities for the translation of drugs already used in different fields into the targeting of tumour-associated fibroblasts with the aim to interrupt their tumour-supportive spur. Finally, the characterisation of relevant stromal gene signatures may improve diagnostic tools for an …
-
Identification of new therapeutic targets and drug repositioning in myelodysplastic syndromes using transcriptional profiling and connectivity mapping
… therapeutic agents in MDS is urgently needed. Drug repurposing is a potential alternative to novel drug discovery by redirecting existing drugs for treating another disease, which dramatically reduces drug development time, cost, and safety risk. In the last few years, gene expression …
-
Analysis for large scale omics data integration, biomarker discovery, drug repositioning and screening for new therapeutic targets for Alzheimer’s Disease
… an automated transcriptomic based drug repositioning pipeline was developed to query the reprocessed Connectivity Map to identify candidate compounds for disease intervention. Drug repositioning the AsymAD gene expression profile identified several candidate compounds that are …
Page 1 of 4